Cellectar Biosciences Stock Forecast - Price Action Indicator
| CLRB Stock | USD 3.54 0.25 6.60% |
Cellectar Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Cellectar Biosciences stock prices and determine the direction of Cellectar Biosciences's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Cellectar Biosciences' historical fundamentals, such as revenue growth or operating cash flow patterns.
At the present time, The RSI of Cellectar Biosciences' share price is at 51 suggesting that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Cellectar Biosciences, making its price go up or down. Momentum 51
Impartial
Oversold | Overbought |
EPS Estimate Next Quarter (2.43) | EPS Estimate Current Year (8.92) | EPS Estimate Next Year (7.52) | Wall Street Target Price 47 | EPS Estimate Current Quarter (2.53) |
Using Cellectar Biosciences hype-based prediction, you can estimate the value of Cellectar Biosciences from the perspective of Cellectar Biosciences response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Cellectar Biosciences using Cellectar Biosciences' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Cellectar using crowd psychology based on the activity and movement of Cellectar Biosciences' stock price.
Cellectar Biosciences Implied Volatility | 0.0 |
Cellectar Biosciences' implied volatility exposes the market's sentiment of Cellectar Biosciences stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Cellectar Biosciences' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Cellectar Biosciences stock will not fluctuate a lot when Cellectar Biosciences' options are near their expiration.
Cellectar Biosciences after-hype prediction price | USD 3.54 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Cellectar | Build AI portfolio with Cellectar Stock |
Open Interest Against 2026-02-20 Cellectar Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Cellectar Biosciences' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Cellectar Biosciences' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Cellectar Biosciences stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Cellectar Biosciences' open interest, investors have to compare it to Cellectar Biosciences' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Cellectar Biosciences is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Cellectar. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Cellectar Biosciences Additional Predictive Modules
Most predictive techniques to examine Cellectar price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Cellectar using various technical indicators. When you analyze Cellectar charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Price Action Indicator | Price Action Indicator | Trend |
| (0.11) | (0.12) |
| Check Cellectar Biosciences Volatility | Backtest Cellectar Biosciences | Information Ratio |
Cellectar Biosciences Trading Date Momentum
| On January 27 2026 Cellectar Biosciences was traded for 3.54 at the closing time. The top price for the day was 3.54 and the lowest listed price was 3.54 . There was no trading activity during the period 0.0. Lack of trading volume on January 27, 2026 did not affect price variability. The overall trading delta against the current closing price is 7.06% . |
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
| Compare Cellectar Biosciences to competition |
Other Forecasting Options for Cellectar Biosciences
For every potential investor in Cellectar, whether a beginner or expert, Cellectar Biosciences' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Cellectar Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Cellectar. Basic forecasting techniques help filter out the noise by identifying Cellectar Biosciences' price trends.Cellectar Biosciences Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Cellectar Biosciences stock to make a market-neutral strategy. Peer analysis of Cellectar Biosciences could also be used in its relative valuation, which is a method of valuing Cellectar Biosciences by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Cellectar Biosciences Market Strength Events
Market strength indicators help investors to evaluate how Cellectar Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cellectar Biosciences shares will generate the highest return on investment. By undertsting and applying Cellectar Biosciences stock market strength indicators, traders can identify Cellectar Biosciences entry and exit signals to maximize returns.
| Rate Of Daily Change | 0.93 | |||
| Day Median Price | 3.54 | |||
| Day Typical Price | 3.54 | |||
| Price Action Indicator | (0.12) | |||
| Period Momentum Indicator | (0.25) | |||
| Relative Strength Index | 51.98 |
Cellectar Biosciences Risk Indicators
The analysis of Cellectar Biosciences' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Cellectar Biosciences' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting cellectar stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.67 | |||
| Standard Deviation | 6.53 | |||
| Variance | 42.65 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Cellectar Biosciences
The number of cover stories for Cellectar Biosciences depends on current market conditions and Cellectar Biosciences' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Cellectar Biosciences is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Cellectar Biosciences' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Cellectar Biosciences Short Properties
Cellectar Biosciences' future price predictability will typically decrease when Cellectar Biosciences' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Cellectar Biosciences often depends not only on the future outlook of the potential Cellectar Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Cellectar Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.2 M | |
| Cash And Short Term Investments | 23.3 M |
Check out Historical Fundamental Analysis of Cellectar Biosciences to cross-verify your projections. For information on how to trade Cellectar Stock refer to our How to Trade Cellectar Stock guide.You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cellectar Biosciences. If investors know Cellectar will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cellectar Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Cellectar Biosciences is measured differently than its book value, which is the value of Cellectar that is recorded on the company's balance sheet. Investors also form their own opinion of Cellectar Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Cellectar Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cellectar Biosciences' market value can be influenced by many factors that don't directly affect Cellectar Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cellectar Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cellectar Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cellectar Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.